논문KCI 등재
Elevation of the Gut Microbiota Metabolite Trimethylamine N-Oxide Predicts Stroke Outcome
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
주제분류신경과학
초록
.
Abstract
.
참고문헌 (3)
- Tang WH, "Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk", N Engl J Med, 368, pp.1575~1584 (2013)
- Haghikia A, "Gut microbiota-dependent trimethylamine Noxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes", Arterioscler Thromb Vasc Biol, 38, pp.2225~2235 (2018)
- Yin J, "Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack", J Am Heart Assoc, 4, pp.e002699~ (2015)
관련 논문AI추천
Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-OxideHyo Suk Nam대한뇌졸중학회 · 대한뇌졸중영문학회지2019 · 제21권 제2호Role of MicroRNAs in Thrombus and Future Vascular Events Among Patients With StrokeHae-Bong Jeong, Hye Ryoun Kim, Hyun-Ho Choi, Jeong-Min Kim, Ju Won Seok, Keun-Hwa Jung, Kwang-Yeol Park, Reeree Lee, Sungguan Hong, Taek-Kyun Nam, Younjoo Moon대한뇌졸중학회 · 대한뇌졸중영문학회지2025 · 제27권 제3호Dissecting Causal Relationships Between Gut Microbiota, Blood Metabolites, and Stroke: A Mendelian Randomization StudyBi Yufang, Dai Huajie, Hou Tianzhichao, Hou Yanan, Li Mian, Lin Hong, Liu Ruixin, Lu Jieli, Ning Guang, Wang Qi, Wang Shuangyuan, Wang Tiange, Wang Weiqing, Xu Min, Xu Yu, Zhao Zhiyun, Zheng Jie, Zheng Ruizhi대한뇌졸중학회 · 대한뇌졸중영문학회지2023 · 제25권 제3호Gut Microbiota and CADASIL: Emerging Insights and Future DirectionsJay Chol Choi대한신경과학회 · Journal of Clinical Neurology2025 · 제21권 제6호Analysis of Gut Microbiota and Their Metabolites in CADASIL PatientsAkiko Watanabe-Hosomi, Daiki Fukunaga, Hiraku Matsuura, Ikuko Mizuta, Jun Matsuura, Ryo Inoue, Tomoyuki Ohara, Toshiki Mizuno, Yuji Naito대한신경과학회 · Journal of Clinical Neurology2025 · 제21권 제6호Biomarkers for Stroke문경준, Oh Young Bang, Suk Jae Kim대한뇌졸중학회 · 대한뇌졸중영문학회지2013 · 제15권 제1호
이 간행물의 다른 논문 (12건)
Tackling Nonatrial Fibrillation Diseases Using Nonvitamin K Antagonist Oral Anticoagulant: by What and for Whom?Jong S. Kimpp. 241-241Digital Therapeutics: Emerging New Therapy for Neurologic Deficits after StrokeHana Kim, Dong-Wha Kang, Hyun-Wook Nah, Mi Joo Choipp. 242-258Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial FibrillationKeun-Sik Hongpp. 259-275Clinical Variables and Genetic Risk Factors Associated with the Acute Outcome of Ischemic Stroke: A Systematic ReviewJin-Moo Lee, Alejandro Bustamante, Joan Martí-Fàbregas, Jerzy Krupinski, Joan Montaner, Nuria P Torres-Aguila, Caty Carrera, Elena Muiño, Natalia Cullell, Jara Cárcel-Márquez, Cristina Gallego-Fabrega, Jonathan González-Sánchez, Pilar Delgado, Laura Ibañez, Laura Heitsch, Carlos Cruchaga, Israel Fernandez-Cadenaspp. 276-289The Incidence of Perioperative Stroke: Estimate Using State and National Databases and Systematic ReviewTudor Jovin, Lawrence R. Wechsler, Parthasarathy D. Thirumala, Rami Al-Hader, Ashutosh Jadhav, Khalid Al-Robaidipp. 290-301